These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 560216)

  • 21. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
    Speight MO; Griffith MJ
    Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of heparin with thrombin and antithrombin III.
    Feinman RD; Li EH
    Fed Proc; 1977 Jan; 36(1):51-5. PubMed ID: 830556
    [No Abstract]   [Full Text] [Related]  

  • 26. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin.
    Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI
    Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the mechanism of the rate-enhancing effect of heparin on the thrombin-antithrombin III reaction.
    Holmer E; Söderström G; Andersson LO
    Eur J Biochem; 1979 Jan; 93(1):1-5. PubMed ID: 436823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic and regulatory functions of N-bromosuccinimide-modified bovine thrombin.
    Pal PK; Starr T; Gertler MM
    Thromb Res; 1984 Nov; 36(4):293-303. PubMed ID: 6523442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A kinetic study on the effects of anticoagulants on the interaction of fibrinogen and thrombin.
    Nakanishi E; Sato H; Nakajima A
    J Biomed Mater Res; 1987 Feb; 21(2):187-200. PubMed ID: 2434508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of heparin-like antithrombotics having perphosphorylated thrombin binding domains.
    Buijsman RC; Basten JE; Dreef-Tromp CM; van der Marel GA; van Boeckel CA; van Boom JH
    Bioorg Med Chem; 1999 Sep; 7(9):1881-90. PubMed ID: 10530936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.
    Blackburn MN; Sibley CC
    J Biol Chem; 1980 Feb; 255(3):824-6. PubMed ID: 7356660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-substrate reaction model for the heparin-catalyzed bovine antithrombin/protease reaction.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1983 Jan; 258(2):1086-91. PubMed ID: 6822493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin reactions with alpha- and gamma-thrombins.
    Chang T; Feinman RD; Landis BH; Fenton JW
    Biochemistry; 1979 Jan; 18(1):113-9. PubMed ID: 420768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method to determine the affinity of heparin to thrombin and antithrombin III on equilibrium gel permeation chromatography.
    Oshima G; Uchiyama H; Nagasawa K
    J Biochem; 1984 Oct; 96(4):1033-9. PubMed ID: 6520110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.
    Hoylaerts M; Owen WG; Collen D
    J Biol Chem; 1984 May; 259(9):5670-7. PubMed ID: 6715365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-sensitive and nonsensitive forms of thrombin.
    Machovich R
    Biochim Biophys Acta; 1975 Jul; 400(1):62-8. PubMed ID: 1170899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet antithrombins: role of thrombin binding and the release of platelet fibrinogen.
    Watanabe K; Chao FC; Tullis JL
    Br J Haematol; 1977 Jan; 35(1):123-33. PubMed ID: 869991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.